Impact of Cottonseed Oil on Oxidative Stress, Inflammation, and Metabolism
NCT05439590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47
Last updated 2023-11-18
Summary
Recent research evidence suggests that cottonseed oil (CSO) may have both direct and indirect anti-inflammatory and anti-oxidative impacts linked to bioactive components of CSO and favorable alterations in lipid metabolism. These impacts are directly related to non-communicable diseases such as diabetes, cardiovascular diseases, and cancer. Our overarching hypothesis is that the effect of CSO consumption on oxidative stress markers (isoprostanes), inflammatory cytokines, metabolic biomarkers, and bile acid metabolism will be beneficial for reversing disease pathophysiology linked to oxidative stress, inflammation, and bile acids. Our long-term goal is to establish effective and practical therapeutic strategies utilizing dietary incorporation of CSO to prevent or reverse these diseases.
The following hypotheses will be tested in the proposed investigation:
H1: CSO consumption will lower exercise-induced oxidative stress, and the effect of CSO will be greater than that of OO for lowering of exercise-induced oxidative stress.
H2: CSO consumption will lower inflammatory cytokines and metabolic markers linked to the inflammation process in human participants, and the effect of CSO will be greater than that of OO for lowering inflammation.
H3: Features of serum bile acids, serum metabolomes, and lipidomes distinguishing CSO and OO treatment correspond to metabolic pathways illuminating the health benefits of CSO treatment.
H4: Metabolic and inflammatory impacts of dietary oils will be greater for 60 g/d of CSO compared to 30 g/d.
Conditions
- Inflammation
- Healthy
- Oxidative Stress
- Metabolic Syndrome
Interventions
- BEHAVIORAL
-
High dose CSO
Participants in the high-dose CSO arm of the study will consume two smoothies containing a total of 60 g of CSO per day for 4 weeks.
- BEHAVIORAL
-
Low dose CSO
Participants in the low-dose CSO arm of the study will consume two smoothies containing a total of 30 g of CSO per day for 4 weeks.
- BEHAVIORAL
-
Low dose OO
Participants in the low-dose OO arm of the study will consume two smoothies containing a total of 30 g of OO per day for 4 weeks.
- BEHAVIORAL
-
High dose OO
Participants in the high-dose OO arm of the study will consume two smoothies containing a total of 60 g of OO per day for 4 weeks.
Sponsors & Collaborators
-
Montana State University
lead OTHER
Principal Investigators
-
Mary P. Miles, PhD · Montana State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-08
- Primary Completion
- 2023-11-03
- Completion
- 2023-11-03
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers in Post-Menopausal Women Receiving Flaxseed
NCT01698294 ·Status: COMPLETED ·Phase: NA
-
Impact of Flaxseed on the Syndrome Metabolic Inflammation
NCT02132728 ·Status: COMPLETED ·Phase: NA
-
Natural Modulators of Immune Function and Mood
NCT05508529 ·Status: COMPLETED ·Phase: NA
-
Exercise and Flax-Based Nutritional Supplementation for Lowering Cholesterol
NCT00204412 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome
NCT05255718 ·Status: COMPLETED ·Phase: NA
-
Coenzyme Q10 and Vitamin A, C, E in Relation to the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome
NCT01412476 ·Status: COMPLETED
-
The Effects of a Nutrition Supplement on Health Related Quality of Life
NCT04499560 ·Status: COMPLETED ·Phase: NA
-
Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors
NCT00927199 ·Status: COMPLETED ·Phase: PHASE2
-
Flaxseed Intervention on Metabolic Syndrome
NCT00733772 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy of Fenugreek Supplementation on Men's Health
NCT03528538 ·Status: COMPLETED ·Phase: NA
-
Effect of Flaxseed on Lipid Uptake and Appetite
NCT00465036 ·Status: COMPLETED ·Phase: NA
-
Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia Population
NCT06060509 ·Status: COMPLETED ·Phase: NA
-
Oral Supplementation With a Black Pepper Extract
NCT05199012 ·Status: COMPLETED ·Phase: NA
-
Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer
NCT00049309 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
NCT03118583 ·Status: COMPLETED ·Phase: NA
-
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
NCT01145066 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Flax in Yogurt on Blood Cyanide Levels
NCT06491095 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer
NCT00794989 ·Status: TERMINATED ·Phase: NA
-
Frankincense Supplements and Inflammation
NCT06488417 ·Status: COMPLETED ·Phase: NA
-
Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils
NCT02337231 ·Status: COMPLETED ·Phase: NA
-
Olive Leaf Extract, Meta-inflammation, Anxiety, and Excess Weight
NCT06485349 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Golden Black Seed: Support of Metabolic Health and General Wellness.
NCT03643094 ·Status: COMPLETED ·Phase: NA
-
The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
NCT02395900 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Canola Oil Multicentre Intervention Trial
NCT01351012 ·Status: COMPLETED ·Phase: NA
-
The Effects of Strawberries on Blood Cholesterol.
NCT03441620 ·Status: COMPLETED ·Phase: NA